Cardiovascular disease (CVD) is the leading cause of death worldwide.1 With advancements in medical and surgical interventions, people are surviving longer following cardiac events and stroke.
The new 2023 Australian Guideline for assessing and managing cardiovascular disease (CVD) risk provides the latest evidence, practical advice and tools for CVD risk assessment and management in primary care.
In recent decades, the management of modifiable risk factors, such as dyslipidaemia, hypertension and hyperglycaemia has undergone significant advancement.2 New and more aggressive pharmacotherapy regimes have driven treatment targets to levels not previously achievable and led to improvements in cardiovascular outcomes.
Last updated02 July 2024